Follow
Célia Touraine
Célia Touraine
ICM (Montpellier Cancer Institute)
Verified email at icm.unicancer.fr
Title
Cited by
Cited by
Year
Gait speed and decline in gait speed as predictors of incident dementia
J Dumurgier, F Artaud, C Touraine, O Rouaud, B Tavernier, C Dufouil, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017
1822017
Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
K Leffondré, C Touraine, C Helmer, P Joly
International journal of epidemiology 42 (4), 1177-1186, 2013
1102013
Distribution-and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
A Ousmen, C Touraine, N Deliu, F Cottone, F Bonnetain, F Efficace, ...
Health and quality of life outcomes 16, 1-12, 2018
962018
Predictions in an illness-death model
C Touraine, C Helmer, P Joly
Statistical methods in medical research 25 (4), 1452-1470, 2016
702016
The SmoothHazard package for R: Fitting regression models to interval-censored observations of illness-death models
C Touraine, TA Gerds, P Joly
Journal of Statistical Software 79 (7), 2017
552017
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review
E Charton, B Cuer, F Cottone, F Efficace, C Touraine, Z Hamidou, F Fiteni, ...
Quality of Life Research 29, 867-878, 2020
252020
Prevalence projections of chronic diseases and impact of public health intervention
P Joly, C Touraine, A Georget, JF Dartigues, D Commenges, ...
Biometrics 69 (1), 109-117, 2013
252013
More accurate cancer-related excess mortality through correcting background mortality for extra variables
C Touraine, N Grafféo, R Giorgi, CENSUR Working Survival Group
Statistical Methods in Medical Research 29 (1), 122-136, 2020
182020
Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring
H Jacqmin-Gadda, P Blanche, E Chary, C Touraine, JF Dartigues
Statistical methods in medical research 25 (6), 2750-2766, 2016
152016
ADL disability and death in dementia in a French population-based cohort: new insights with an illness-death model
F Delva, C Touraine, P Joly, A Edjolo, H Amieva, C Berr, O Rouaud, ...
Alzheimer's & Dementia 12 (8), 909-916, 2016
122016
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results
C Bascoul-Mollevi, A Barbieri, C Bourgier, T Conroy, B Chauffert, ...
Quality of Life Research 30, 91-103, 2021
112021
Modèles illness-death pour données censurées par intervalle: application à l'étude de la démence
C Touraine
Bordeaux 2, 2013
112013
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial …
B Cuer, C Mollevi, A Anota, E Charton, B Juzyna, T Conroy, C Touraine
BMC medical research methodology 20, 1-13, 2020
92020
A new score to predict the resectability of pancreatic adenocarcinoma: The BACAP score
C Maulat, C Canivet, C Touraine, S Gourgou, B Napoleon, L Palazzo, ...
Cancers 12 (4), 783, 2020
82020
Correcting for misclassification and selection effects in estimating net survival in clinical trials
JA Goungounga, C Touraine, N Grafféo, R Giorgi, ...
BMC Medical Research Methodology 19, 1-14, 2019
62019
SmoothHazard: Fitting illness-death model for interval-censored data
C Touraine, P Joly, TA Gerds
R package version 1.2 3, 2014
62014
the CENSUR Working Survival Group.(2020). More accurate cancer-related excess mortality through correcting background mortality for extra variables
C Touraine, N Grafféo, R Giorgi
Statistical Methods in Medical Research 29 (1), 122-136, 0
6
Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials
B Cuer, T Conroy, B Juzyna, S Gourgou, C Mollevi, C Touraine
Quality of Life Research, 1-12, 2022
52022
A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
E Chartron, N Firmin, C Touraine, A Chapelle, E Legouffe, L Rifai, ...
Nutrients 13 (12), 4429, 2021
52021
SmoothHazard: Fitting illness-death model for interval-censored data. R package version 1.0. 9
C Touraine, P Joly, TA Gerds
CRAN Repository, 2013
52013
The system can't perform the operation now. Try again later.
Articles 1–20